Highlights

  • DGL manufactures, formulates and blends industrial and specialty chemicals, and complements that with warehousing, distribution and waste-disposal and recycling services through a licensed network — an.
  • DGL's FY25 accounts (year to June 2025) capture the problem.
  • The immediate swing Factor is the 28 August result.
  • The risks are tangible.

DGL manufactures, formulates and blends industrial and specialty chemicals, and complements that with warehousing, distribution and waste-disposal and recycling services through a licensed network — an integrated model spanning production and hazardous-goods logistics, headquartered in Parramatta, New South Wales. The defining recent feature is ownership concentration: Simon Henry holds roughly 53 per cent of the company, and between April and May 2026 he purchased additional shares at prices around 38 to 40 cents. Insider buying of that kind, by a founder already holding a majority, is a meaningful vote of confidence in the recovery thesis, though it also underscores how far the price has fallen.

Latest company developments

DGL manufactures, formulates and blends industrial and specialty chemicals, and complements that with warehousing, distribution and waste-disposal and recycling services through a licensed network — an integrated model spanning production and hazardous-goods logistics, headquartered in Parramatta, New South Wales. The defining recent feature is ownership concentration: Simon Henry holds roughly 53 per cent of the company, and between April and May 2026 he purchased additional shares at prices around 38 to 40 cents. Insider buying of that kind, by a founder already holding a majority, is a meaningful vote of confidence in the recovery thesis, though it also underscores how far the price has fallen. The company's reporting calendar points to preliminary results on 28 August 2026 and an Annual Report on 16 October 2026, making the next fortnight the key window for fresh operational and financial detail.

Financial and operating picture

DGL's FY25 accounts (year to June 2025) capture the problem. Revenue was broadly flat at about $455.3 million, up marginally from roughly $450.7 million in FY24, so the issue was profitability rather than demand. EBITDA fell sharply to around $41.3 million from about $64.8 million, and the company swung to a net loss of roughly $27.9 million from a $14.3 million profit the year before — a Reversal driven in part by around $26.9 million of abnormal charges. Just as important is the balance sheet: net Debt sat near $161 million, a significant load for a Business whose Earnings have compressed. That combination — flat revenue, halved EBITDA, a statutory loss and material gearing — frames the FY26 result as a referendum on whether management can rebuild margins and service its debt comfortably. The direction of underlying EBITDA and net debt will matter more than the headline profit line.

What to watch next

The immediate swing factor is the 28 August result. Evidence that EBITDA has stabilised or begun to recover, that abnormal charges have washed through, and that net debt is trending lower would support the view that FY25 marked the trough. Chemical-sector conditions matter too: firmer product pricing, better plant utilisation and easing input costs would flow through to margins. Continued insider buying, or a clear capital-management plan to reduce gearing, could improve confidence. Because Simon Henry controls a majority stake, corporate-action optionality — including any move to simplify or privatise — is a recurring theme for stocks with this ownership structure, though nothing specific is confirmed. On the operational side, cost-out initiatives and disposals of non-core Assets to pay down debt would be viewed positively.

Risks

The risks are tangible. The most pressing is leverage: net debt near $161 million against compressed earnings leaves limited headroom, and any further deterioration in EBITDA would sharpen concerns about debt serviceability and covenant comfort. The FY25 swing to a loss, even allowing for abnormals, shows the earnings base is volatile and exposed to chemical prices, Demand cycles and input costs. The dominant founder stake, while aligning insider and Shareholder interests, concentrates control and can leave minority holders with limited influence over strategy or any corporate action. Operating hazardous-chemicals and waste facilities carries environmental, safety and Regulatory Risk that can generate one-off costs.

Outlook

DGL Group is a turnaround-in-waiting: a scaled chemicals-and-logistics business with steady revenue but a badly damaged earnings profile and meaningful debt. The upside case is that FY25 was the low point, that abnormal charges are behind it, and that a founder-CEO buying stock sees value the market is missing. The downside case centres on gearing and Margin fragility — a business that halved its EBITDA and fell into loss cannot be assumed to have stabilised until the numbers say so. The report's detail on underlying EBITDA, abnormal items and net debt will be the decisive evidence on whether the recovery has genuinely begun.